Alonazi NA, Hundallah KJ, Al Hashem AM, Mohamed S (2018). A novel variant in ATM gene causes ataxia telangiectasia revealed by whole-exome sequencing. Neurosciences (Riyadh, Saudi Arabia), 23(2), 162–164. https://doi.org/10.17712/nsj.2018.2.20170463
Choi M, Kipps T, Kurzrock R (2016). ATM Mutations in Cancer: Therapeutic Implications. Molecular cancer therapeutics, 15(8), 1781–1791. https://doi.org/10.1158/1535-7163.MCT-15-0945
Daly MB, Pal T, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hendrix A, Hutton ML, Karlan BY, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Mansour J, McDonnel K, et al. (2021) NCCN Clinical practice guidelines in oncology genetic/familial high-risk assessment: breast and ovarian (Version 12022) In: NCCN Clinical Practice Guidelines in Oncology; 2021
Hall MJ, Bernhisel R, Hughes E, Larson K, Rosenthal ET, Singh NA, Lancaster JM, Kurian AW (2021) Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers Cancer prevention research (Philadelphia Pa) 14(4) 433–440 https://doiorg/101158/1940-6207CAPR-20-0448
Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K, Zogopoulos G, Santos TA, Claro I, Carvalho J, Nielsen C, Padilla S, Lum A, Talhouk A, Baker-Lange K, Richardson S, Lewis et al. (2015) Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond JAMA oncology 1(1) 23–32 https://doiorg/101001/jamaoncol2014168
Helgason H, Rafnar T, Olafsdottir HS, Jonasson JG, Sigurdsson A, Stacey SN, Jonasdottir A, Tryggvadottir L, Alexiusdottir K, Haraldsson A, le Roux L, Gudmundsson J, Johannsdottir H, Oddsson A, Gylfason A, Magnusson OT, Masson G, Jonsson T, Skuladottir H, Gudbjartsson D F, et al. (2015) Loss-of-function variants in ATM confer risk of gastric cancer Nature genetics 47(8) 906–910 https://doiorg/101038/ng3342
Huang DS, Tao HQ, He XJ, Long M, Yu S, Xia YJ, Wei Z, Xiong Z, Jones S, He Y, Yan H , Wang X (2015) Prevalence of deleterious ATM germline mutations in gastric cancer patients Oncotarget 6(38) 40953–40958 https://doiorg/1018632/oncotarget5944
Jerzak KJ, Mancuso T, Eisen, A (2018) Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review Current oncology (Toronto Ont) 25(2) e176–e180 https://doiorg/103747/co253707
McKinley SK, Singh P, Yin K, Wang J, Zhou J, Bao Y, Wu M, Pathak K, Mullen JT, Braun D , Hughes KS (2021) Disease spectrum of gastric cancer susceptibility genes Medical oncology (Northwood London England) 38(5) 46 https://doiorg/101007/s12032-021-01495-w
Zaki-Dizaji M, Akrami SM, Abolhassani H, Rezaei N, Aghamohammadi A (2017) Ataxia telangiectasia syndrome: moonlighting ATM Expert review of clinical immunology 13(12) 1155–1172 https://doiorg/101080/1744666X20171392856